Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Centers for Disease Control and Prevention (CDC)
Abstract
We decreased antimicrobial drug consumption in an intensive care unit in Lebanon by changing to colistin monotherapy for extensively drug-resistant Acinetobacter baumanii infections. We saw a 78% decrease of A. baumanii in sputum and near-elimination of blaoxa-23-carrying sequence type 2 clone over the 1-year study. Non-A. baumanii multidrug-resistant infections remained stable. © 2019 Centers for Disease Control and Prevention (CDC). All rights reserved.
Description
Keywords
Acinetobacter baumannii, Acinetobacter infections, Aged, Anti-bacterial agents, Antimicrobial stewardship, Cross infection, Disease eradication, Drug resistance, multiple, bacterial, Female, Humans, Intensive care units, Lebanon, Male, Sputum, Amikacin, Amoxicillin plus clavulanic acid, Antiinfective agent, Carbapenem, Cefepime, Ceftazidime, Colistin, Extended spectrum beta lactamase, Imipenem, Meropenem, Metronidazole, Piperacillin plus tazobactam, Quinolone derivative, Tigecycline, Vancomycin, Amoxicillin, Cephalosporin, Clavulanic acid, Acinetobacter infection, Antibiotic sensitivity, Article, Bacterial gene, Bacterium isolation, Bla oxa 23 gene, Case fatality rate, Controlled study, Disease control, Disease elimination, Disk diffusion, Hospital mortality, Human, Incidence, Intensive care unit, Major clinical study, Matrix-assisted laser desorption-ionization mass spectrometry, Multilocus sequence typing, Nonhuman, Real time polymerase chain reaction, Sputum culture, Ventilator associated pneumonia, Extensively drug resistant acinetobacter baumannii, Matrix assisted laser desorption ionization time of flight mass spectrometry, Monotherapy, Drug effect, Epidemiology, Microbiology, Multidrug resistance, Procedures